Real-World Treatment Patterns and Healthcare Costs in Patients with Psoriatic Arthritis Treated with Ixekizumab: A Retrospective Study.
Mwangi J MuragePrincic NicoleJulie ParkWilliam MalatestinicBaojin ZhuBilal AtiyaScott A KernKeri B StengerAubrey Trevelin SpraberyAlexis OgdiePublished in: ACR open rheumatology (2021)
Results from this real-world analysis suggest that treatment patterns and costs among patients with PsA initiating IXE are consistent with prior literature for other biologics.